Suppr超能文献

多糖对肝损伤的保护作用:综述。

Protective effects of polysaccharides on hepatic injury: A review.

机构信息

Department of Medicine Laboratory, First Hospital, Jilin University, Changchun 130021, China.

Department of Infectious Disease, First Hospital, Jilin University, Changchun 130021, China.

出版信息

Int J Biol Macromol. 2019 Dec 1;141:822-830. doi: 10.1016/j.ijbiomac.2019.09.002. Epub 2019 Sep 2.

Abstract

Chronic hepatic injury caused by hepatitis B and C virus (HBV and HCV) infection, high fat diet and alcohol intake has increased to be the critical promoter of hepatocellular carcinoma (HCC). These high risk factors set into motion a vicious cycle of hepatocyte death, inflammation and fibrosis that finally results in cirrhosis and HCC after several decades. However, the treatment options for HCC are very limited. Therefore, early treatment of liver injury may reduce the incidence and probability of HCC or delay the progression of HCC. Substantial ongoing research has focused on nontoxic biological macromolecules, mainly polysaccharides, which possess prominent efficacies on hepatoprotective activity. Based on these encouraging observations, a great deal of effort has been devoted to discovering novel polysaccharides for the development of effective therapeutics for hepatic injury. This review focuses on the protective effects of polysaccharides on liver injury, including hepatitis virus infection, nonalcoholic steatohepatitis, alcoholic liver disease and other hepatic injuries, and describes the underlying mechanisms.

摘要

由乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染、高脂肪饮食和酒精摄入引起的慢性肝损伤已成为肝细胞癌(HCC)的重要促进因素。这些高危因素引发了肝细胞死亡、炎症和纤维化的恶性循环,几十年后最终导致肝硬化和 HCC。然而,HCC 的治疗选择非常有限。因此,早期治疗肝损伤可能会降低 HCC 的发病率和概率,或延缓 HCC 的进展。大量正在进行的研究集中在无毒的生物大分子上,主要是多糖,它们在保肝活性方面具有显著的功效。基于这些令人鼓舞的观察结果,人们投入了大量精力来发现新型多糖,以开发有效的肝损伤治疗药物。本文综述了多糖对肝损伤的保护作用,包括肝炎病毒感染、非酒精性脂肪性肝炎、酒精性肝病和其他肝损伤,并描述了其潜在机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验